Who Should Consider GLP-1 Therapy FDA indications for weight loss require: BMI 30 (obesity), or BMI 27 (overweight) with at least one weight-related condition hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or similar These thresholds set eligibility, but they don't answer the more important question: who benefits most
This can help you and your healthcare provider make adjustments to your treatment plan
10.1016/S0091-6749(00)90044-7 16 BennettW
Safety is a common concern with any IV treatment, and its wise to ask, Is glutathione IV safe for me? Generally speaking, glutathione IV therapy is considered safe for most healthy adults when administered by qualified medical professionals
Storing GLP-1: Best Practices For Safety And Potency Youve picked up your GLP-1 prescription, ready to commit to a new chapter in weight loss and metabolic health
Novo Nordisk will use its expertise in peptide and protein therapeutics to lead development and commercialisation
